How big is the Iran Diabetes Care Devices Market?

April 2023: Medtronic plc has recently received approval from the U.S. Food and Drug Administration (FDA) for its MiniMed 780G system, which incorporates the Guardian 4 sensor and utilizes SmartGuard technology. Notably, this advanced system eliminates the need for fingersticks.
February 2022: Drug firm Abbott announced it has tied up with various health-tech firms like BeatO, and Sugar.fit, PharmEasy, GOQii, 1MG, and Zyla for diabetes care. The company has also joined hands with Health, HealthifyMe, and Fitterfly under the initiative.

The Iran Diabetes Care Devices Market size is expected to reach USD 752.91 million in 2024 and grow at a CAGR of 4.5% to reach USD 938.26 million by 2029. Read More

What is the current Iran Diabetes Care Devices Market size?

In 2024, the Iran Diabetes Care Devices Market size is expected to reach USD 752.91 million. Read More

Who are the key players in Iran Diabetes Care Devices Market?

Medtronic, Roche, NovoNordisk, Abbott and Dexcom are the major companies operating in the Iran Diabetes Care Devices Market. Read More

What years does this Iran Diabetes Care Devices Market cover, and what was the market size in 2023?

In 2023, the Iran Diabetes Care Devices Market size was estimated at USD 719.03 million. The report covers the Iran Diabetes Care Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Iran Diabetes Care Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More